Among infants receiving fluconazole , the composite primary end point of death or invasive candidiasis was 16 % ( 95 % CI , 11 % -22 % ) vs 21 % in the placebo group ( 95 % CI , 15 % -28 % ; odds ratio , 0.73 [ 95 % CI , 0.43-1 .23 ] ; P = .24 ; treatment difference , -5 % [ 95 % CI , -13 % to 3 % ] ) .